Aripiprazole lauroxil
Aripiprazole lauroxil, aslo known as RDC 3317, is a long-acting injectable atypical antipsychotic. It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia. Aripiprazole lauroxil was approved by the U.S. FDA on 5 October 2015.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1384 |
| CAS # | 1259305-29-7 (lauroxil) |
| Pricing | Customizable size, Inquiry |
| Synonym | RDC 3317; RDC-3317; RDC3317; ALKS9072; ALKS-9072; ALKS 9072;Aripiprazole lauroxil; Aristada. |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C36H51Cl2N3O4 |
| Exact Mass | 659.3257 |
| Molecular Weight | 660.721 |
| Elemental Analysis | C, 65.44; H, 7.78; Cl, 10.73; N, 6.36; O, 9.69 |
| IUPAC/Chemical Name | (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl dodecanoate |
| InChi Key | DDINXHAORAAYAD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3 |
| SMILES Code | O=C1N(COC(CCCCCCCCCCC)=O)C2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)CC1 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Availability | 2 Weeks |